Cabot (NYSE:CBT) Updates FY 2026 Earnings Guidance

Cabot (NYSE:CBT) updated its FY 2026 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 6.150-6.450 for the period, compared to the consensus estimate of 6.320. The company issued revenue guidance of -.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. JPMorgan Chase & Co. upped their price target on Cabot from $68.00 to $70.00 and gave the company an “underweight” rating in a research report on Wednesday, May 13th. Wall Street Zen downgraded shares of Cabot from a “buy” rating to a “hold” rating in a research report on Saturday. Truist Financial started coverage on Cabot in a research note on Monday, June 8th. They issued a “buy” rating and a $98.00 price target on the stock. Mizuho increased their target price on Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a research note on Thursday, June 25th. Finally, UBS Group boosted their price objective on shares of Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a report on Friday, May 8th. Two analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $85.80.

Cabot Price Performance

NYSE CBT opened at $81.51 on Wednesday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.96 and a current ratio of 1.45. The business’s fifty day moving average is $87.96 and its 200 day moving average is $79.62. The company has a market capitalization of $4.21 billion, a PE ratio of 15.41, a price-to-earnings-growth ratio of 11.63 and a beta of 0.84. Cabot has a fifty-two week low of $58.33 and a fifty-two week high of $94.53.

Cabot (NYSE:CBT) last posted its quarterly earnings data on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, beating analysts’ consensus estimates of $1.66 by $0.01. Cabot had a return on equity of 20.37% and a net margin of 5.23%.The firm had revenue of $982.00 million for the quarter, compared to analysts’ expectations of $943.16 million. During the same period in the previous year, the firm earned $1.90 EPS. The business’s quarterly revenue was up 6.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Sell-side analysts predict that Cabot will post 6.37 earnings per share for the current year.

Cabot Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be paid a dividend of $0.4725 per share. The ex-dividend date is Friday, August 28th. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.3%. Cabot’s payout ratio is 35.73%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CBT. Geneos Wealth Management Inc. lifted its holdings in shares of Cabot by 409.0% in the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after buying an additional 364 shares in the last quarter. Global Retirement Partners LLC lifted its stake in Cabot by 1,606.9% in the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock worth $33,000 after purchasing an additional 466 shares in the last quarter. Danske Bank A S bought a new position in shares of Cabot during the 3rd quarter valued at about $38,000. Caitong International Asset Management Co. Ltd increased its holdings in shares of Cabot by 709.1% in the third quarter. Caitong International Asset Management Co. Ltd now owns 534 shares of the specialty chemicals company’s stock worth $41,000 after purchasing an additional 468 shares during the last quarter. Finally, Advisory Services Network LLC bought a new stake in shares of Cabot in the third quarter worth about $57,000. 93.18% of the stock is currently owned by institutional investors.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.